PGK1 and prostate cancer: Consistently, Wa et al. have identified that miR-30b has the capacity to inhibit early chondrogenic differentiation of mouse embryo‐derived stem cells [40], and a former study has unveiled that the prostate cancer-derived PGK1 could induce osteoblastic differentiation of bone marrow stromal cells [41].